News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
China BioPharma Ltd. Appoints Dr. Yimin Yu, Current Chairman Of HYTE Research To Advisory Board
April 20, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ISELIN, N.J.--(BUSINESS WIRE)--April 20, 2006--Techedge Inc. (OTCBB:TEDG - News) announced that China BioPharma, Ltd. has appointed Dr. Yimin Yu, the current Chairman of HYTE Research, LLC to the company's Board of Advisors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
September 29, 2026
·
3 min read
·
Tristan Manalac
China
Novo adds long-term obesity differentiation in up to $2.6B Hengrui deal
September 29, 2026
·
2 min read
·
Annalee Armstrong
Eye disease
Kodiak Sciences’ stock soars 166% after 2 assets match Eylea in Phase 3 trial
September 28, 2026
·
1 min read
·
Gabrielle Masson
Licensing
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor
September 28, 2026
·
2 min read
·
Gabrielle Masson
